drugset / Trial / NCT01280344
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Post-operative administration of ipamorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial small and/or large bowel resection.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-06
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipamorelin | Protein / enzyme biologic | 0.03 mg/kg | Intravenous |
| Subject | Ipamorelin | Protein / enzyme biologic | 0.06 mg/kg | Intravenous |